Acyclovir-resistant Mucocutaneous Herpes Simplex Virus Infections

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2023-11-29
FDA Approved: FOSCARNET SODIUM — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved the original application for Foscarnet Sodium, a generic antiviral intended for CMV and acyclovir-resistant HSV infections.